Skip to main content
. 2015 Apr 20;7(2):154–160. doi: 10.5114/jcb.2015.51095

Fig. 4.

Fig. 4

Progression-free survival of all patients with metastatic malignant melanoma treated with high-dose-rate brachytherapy